Title | Type | SJR | H index | Total Docs. (2017) | Total Docs. (3years) | Total Refs. (2017) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2017) | %Female (2017) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Molecular Imaging and Biology | journal | 1.142 Q2 | 78 | 110 | 304 | 4141 | 999 | 298 | 3.69 | 37.65 | 35.90 | |
52 | American Journal of Translational Research (discontinued) | journal | 1.080 Q2 | 80 | 497 | 854 | 18961 | 2822 | 852 | 3.21 | 38.15 | 38.74 | |
53 | Current Hematologic Malignancy Reports | journal | 1.072 Q2 | 44 | 70 | 167 | 4382 | 407 | 167 | 2.60 | 62.60 | 33.53 | |
54 | Sub-Cellular Biochemistry | journal | 1.026 Q2 | 81 | 53 | 294 | 7033 | 685 | 280 | 1.82 | 132.70 | 28.43 | |
55 | European Journal of Cancer Prevention | journal | 1.021 Q2 | 88 | 108 | 249 | 3719 | 556 | 225 | 2.18 | 34.44 | 51.45 | |
56 | Clinical Breast Cancer | journal | 1.000 Q3 | 80 | 115 | 302 | 4088 | 798 | 290 | 2.61 | 35.55 | 49.63 | |
57 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 0.973 Q3 | 90 | 105 | 316 | 3053 | 765 | 303 | 2.65 | 29.08 | 33.92 | |
58 | Critical Reviews in Oncogenesis | journal | 0.946 Q3 | 57 | 41 | 111 | 3727 | 226 | 99 | 1.76 | 90.90 | 46.96 | |
59 | Oncology Research | journal | 0.896 Q3 | 76 | 163 | 149 | 4892 | 439 | 149 | 2.76 | 30.01 | 36.16 | |
60 | Clinical Lymphoma, Myeloma and Leukemia | journal | 0.895 Q3 | 65 | 156 | 477 | 5858 | 951 | 439 | 2.14 | 37.55 | 39.08 | |
61 | Current Problems in Cancer | journal | 0.895 Q3 | 47 | 39 | 73 | 2094 | 121 | 61 | 1.67 | 53.69 | 45.95 | |
62 | Cancer Investigation | journal | 0.858 Q3 | 93 | 72 | 198 | 2763 | 457 | 198 | 2.13 | 38.38 | 35.38 | |
63 | Medical Oncology | journal | 0.757 Q3 | 90 | 198 | 1027 | 8407 | 2961 | 997 | 2.94 | 42.46 | 38.25 | |
64 | Nutrition and Cancer | journal | 0.745 Q3 | 130 | 139 | 442 | 6855 | 1152 | 437 | 2.48 | 49.32 | 44.91 | |
65 | Anti-Cancer Drugs | journal | 0.716 Q3 | 102 | 110 | 430 | 4425 | 873 | 425 | 1.77 | 40.23 | 39.75 | |
66 | Nuclear Medicine and Biology | journal | 0.696 Q3 | 98 | 100 | 365 | 3603 | 815 | 354 | 2.28 | 36.03 | 32.07 | |
67 | Oncology | journal | 0.691 Q3 | 83 | 146 | 717 | 3152 | 616 | 580 | 0.75 | 21.59 | 39.46 | |
68 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.567 Q3 | 68 | 46 | 167 | 1728 | 277 | 163 | 1.57 | 37.57 | 39.35 | |
69 | Technology in Cancer Research and Treatment | journal | 0.559 Q3 | 72 | 143 | 258 | 4712 | 488 | 257 | 1.69 | 32.95 | 33.61 | |
70 | American Journal of Blood Research | journal | 0.347 Q4 | 6 | 0 | 8 | 0 | 10 | 8 | 2.00 | 0.00 | 0.00 | |
71 | Journal of Cancer Science and Therapy (discontinued) | journal | 0.202 Q4 | 22 | 0 | 43 | 0 | 35 | 39 | 0.00 | 0.00 | 0.00 | |
72 | Journal of Experimental Therapeutics and Oncology | journal | 0.201 Q4 | 40 | 25 | 65 | 566 | 36 | 65 | 0.44 | 22.64 | 31.37 | |
73 | International Journal of Endocrine Oncology | journal | 0.185 Q4 | 1 | 0 | 3 | 0 | 1 | 3 | 0.33 | 0.00 | 0.00 | |
74 | Cancer Therapy | journal | 0.164 Q4 | 9 | 0 | 4 | 0 | 5 | 4 | 0.00 | 0.00 | 0.00 | |
75 | Annals of Cancer Research and Therapy | journal | 0.148 Q4 | 7 | 24 | 22 | 301 | 6 | 19 | 0.21 | 12.54 | 11.11 | |
76 | Current Pathobiology Reports | journal | 33 | 34 | 85 | 3128 | 140 | 85 | 1.59 | 92.00 | 42.31 | ||
77 | JCO clinical cancer informatics | journal | 33 | 44 | 0 | 1213 | 0 | 0 | 0.00 | 27.57 | 34.37 | ||
78 | JCO Global Oncology | journal | 39 | 109 | 0 | 3031 | 0 | 0 | 0.00 | 27.81 | 41.53 | ||
79 | JCO Precision Oncology | journal | 48 | 102 | 0 | 3303 | 0 | 0 | 0.00 | 32.38 | 39.68 | ||
80 | JNCI Cancer Spectrum | journal | 33 | 9 | 0 | 347 | 0 | 0 | 0.00 | 38.56 | 58.93 | ||
81 | Journal of Environmental Science and Health, Part C: Toxicology and Carcinogenesis | journal | 59 | 14 | 43 | 1058 | 211 | 43 | 4.93 | 75.57 | 36.62 | ||
82 | National Toxicology Program technical report series | journal | 22 | 2 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®